Myocardial Recovery and the Failing Heart: Myth, Magic, or Molecular Target?
- 18 December 2012
- journal article
- review article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 60 (24), 2465-2472
- https://doi.org/10.1016/j.jacc.2012.06.062
Abstract
No abstract availableFunding Information
- National Institutes of Health (RO1 HL58081, RO1 HL61543, RO1 HL-42250)
This publication has 41 references indexed in Scilit:
- Myocardial Expression Levels of Micro-Ribonucleic Acids in Patients With Left Ventricular Assist Devices: Signature of Myocardial Recovery, Signature of Reverse Remodeling, or Signature With No Name?Journal of the American College of Cardiology, 2011
- Reverse Remodeling With Left Ventricular Assist DevicesCirculation: Heart Failure, 2011
- Myocardial Reverse RemodelingCardiovascular Therapeutics, 2010
- Heart failure reversal by ventricular unloading in patients with chronic cardiomyopathy: criteria for weaning from ventricular assist devicesEuropean Heart Journal, 2010
- Peripartum cardiomyopathy: A comprehensive reviewInternational Journal of Cardiology, 2007
- Left Ventricular Assist Device and Drug Therapy for the Reversal of Heart FailureThe New England Journal of Medicine, 2006
- Mixed MessagesCirculation Research, 2005
- Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device supportThe Journal of Heart and Lung Transplantation, 2005
- Thymidylate Synthase Protein Expression in Primary Colorectal Cancer: Lack of Correlation With Outcome and Response to Fluorouracil in Metastatic Disease SitesJournal of Clinical Oncology, 2003
- A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracilEuropean Journal of Cancer, 1994